These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 33371873)
21. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study. Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133 [TBL] [Abstract][Full Text] [Related]
22. Functional brain network centrality is related to APOE genotype in cognitively normal elderly. Wink AM; Tijms BM; Ten Kate M; Raspor E; de Munck JC; Altena E; Ecay-Torres M; Clerigue M; Estanga A; Garcia-Sebastian M; Izagirre A; Martinez-Lage Alvarez P; Villanua J; Barkhof F; Sanz-Arigita E Brain Behav; 2018 Sep; 8(9):e01080. PubMed ID: 30136422 [TBL] [Abstract][Full Text] [Related]
23. APOE ε4 influences within and between network functional connectivity in posterior cortical atrophy and logopenic progressive aphasia. Singh NA; Martin PR; Graff-Radford J; Machulda MM; Carrasquillo MM; Ertekin-Taner N; Josephs KA; Whitwell JL Alzheimers Dement; 2023 Sep; 19(9):3858-3866. PubMed ID: 36999481 [TBL] [Abstract][Full Text] [Related]
24. Genotypic effects of APOE-ε4 on resting-state connectivity in cognitively intact individuals support functional brain compensation. Cacciaglia R; Operto G; Falcón C; de Echavarri-Gómez JMG; Sánchez-Benavides G; Brugulat-Serrat A; Milà-Alomà M; Blennow K; Zetterberg H; Molinuevo JL; Suárez-Calvet M; Gispert JD; Cereb Cortex; 2023 Mar; 33(6):2748-2760. PubMed ID: 35753703 [TBL] [Abstract][Full Text] [Related]
25. Network dysfunction in cognitively normal APOE ε4 carriers is related to subclinical tau. Butt OH; Meeker KL; Wisch JK; Schindler SE; Fagan AM; Benzinger TLS; Cruchaga C; Holtzman DM; Morris JC; Ances BM Alzheimers Dement; 2022 Jan; 18(1):116-126. PubMed ID: 34002449 [TBL] [Abstract][Full Text] [Related]
26. Recognition memory is associated with altered resting-state functional connectivity in people at genetic risk for Alzheimer's disease. Matura S; Prvulovic D; Butz M; Hartmann D; Sepanski B; Linnemann K; Oertel-Knöchel V; Karakaya T; Fußer F; Pantel J; van de Ven V Eur J Neurosci; 2014 Oct; 40(7):3128-35. PubMed ID: 24989884 [TBL] [Abstract][Full Text] [Related]
28. Neuroimaging basis in the conversion of aMCI patients with APOE-ε4 to AD: study protocol of a prospective diagnostic trial. Chen GQ; Sheng C; Li YX; Yu Y; Wang XN; Sun Y; Li HY; Li XY; Xie YY; Han Y BMC Neurol; 2016 May; 16():64. PubMed ID: 27176479 [TBL] [Abstract][Full Text] [Related]
29. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons. Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820 [TBL] [Abstract][Full Text] [Related]
30. The ε4 genotype of apolipoprotein E and white matter integrity in Alzheimer's disease. Kljajevic V; Meyer P; Holzmann C; Dyrba M; Kasper E; Bokde AL; Fellgiebel A; Meindl T; Hampel H; Teipel S; Alzheimers Dement; 2014 May; 10(3):401-4. PubMed ID: 23706516 [TBL] [Abstract][Full Text] [Related]
31. MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study. Ten Kate M; Redolfi A; Peira E; Bos I; Vos SJ; Vandenberghe R; Gabel S; Schaeverbeke J; Scheltens P; Blin O; Richardson JC; Bordet R; Wallin A; Eckerstrom C; Molinuevo JL; Engelborghs S; Van Broeckhoven C; Martinez-Lage P; Popp J; Tsolaki M; Verhey FRJ; Baird AL; Legido-Quigley C; Bertram L; Dobricic V; Zetterberg H; Lovestone S; Streffer J; Bianchetti S; Novak GP; Revillard J; Gordon MF; Xie Z; Wottschel V; Frisoni G; Visser PJ; Barkhof F Alzheimers Res Ther; 2018 Sep; 10(1):100. PubMed ID: 30261928 [TBL] [Abstract][Full Text] [Related]
32. The effect of APOE ε4 allele on cholinesterase inhibitors in patients with Alzheimer disease: evaluation of the feasibility of resting state functional connectivity magnetic resonance imaging. Wang L; Day J; Roe CM; Brier MR; Thomas JB; Benzinger TL; Morris JC; Ances BM Alzheimer Dis Assoc Disord; 2014; 28(2):122-7. PubMed ID: 24830360 [TBL] [Abstract][Full Text] [Related]
33. ABCA7 polymorphisms correlate with memory impairment and default mode network in patients with APOEε4-associated Alzheimer's disease. Chang YT; Hsu SW; Huang SH; Huang CW; Chang WN; Lien CY; Lee JJ; Lee CC; Chang CC Alzheimers Res Ther; 2019 Dec; 11(1):103. PubMed ID: 31831047 [TBL] [Abstract][Full Text] [Related]
34. Episodic memory of APOE ε4 carriers is correlated with fractional anisotropy, but not cortical thickness, in the medial temporal lobe. Westlye ET; Hodneland E; Haász J; Espeseth T; Lundervold A; Lundervold AJ Neuroimage; 2012 Oct; 63(1):507-16. PubMed ID: 22796460 [TBL] [Abstract][Full Text] [Related]
35. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease. Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913 [TBL] [Abstract][Full Text] [Related]
36. Disrupted Brain Structural Connectivity: Pathological Interactions Between Genetic APOE ε4 Status and Developed MCI Condition. Ma C; Wang J; Zhang J; Chen K; Li X; Shu N; Chen Y; Liu Z; Zhang Z Mol Neurobiol; 2017 Nov; 54(9):6999-7007. PubMed ID: 27785756 [TBL] [Abstract][Full Text] [Related]
37. White matter microstructure is altered in cognitively normal middle-aged APOE-ε4 homozygotes. Operto G; Cacciaglia R; Grau-Rivera O; Falcon C; Brugulat-Serrat A; Ródenas P; Ramos R; Morán S; Esteller M; Bargalló N; Molinuevo JL; Gispert JD; Alzheimers Res Ther; 2018 May; 10(1):48. PubMed ID: 29793545 [TBL] [Abstract][Full Text] [Related]
38. Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo. Pievani M; Rasser PE; Galluzzi S; Benussi L; Ghidoni R; Sabattoli F; Bonetti M; Binetti G; Thompson PM; Frisoni GB Neuroimage; 2009 May; 45(4):1090-8. PubMed ID: 19349226 [TBL] [Abstract][Full Text] [Related]
39. Nonlinear interaction between APOE ε4 allele load and age in the hippocampal surface of cognitively intact individuals. Martí-Juan G; Sanroma-Guell G; Cacciaglia R; Falcon C; Operto G; Molinuevo JL; González Ballester MÁ; Gispert JD; Piella G; ; Hum Brain Mapp; 2021 Jan; 42(1):47-64. PubMed ID: 33017488 [TBL] [Abstract][Full Text] [Related]
40. Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele. Langbaum JB; Chen K; Caselli RJ; Lee W; Reschke C; Bandy D; Alexander GE; Burns CM; Kaszniak AW; Reeder SA; Corneveaux JJ; Allen AN; Pruzin J; Huentelman MJ; Fleisher AS; Reiman EM Arch Neurol; 2010 Apr; 67(4):462-8. PubMed ID: 20385913 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]